市场调查报告书
商品编码
1134986
睪固酮替代疗法的全球市场规模调查&预测,各产品,各地区分析,2022-2029年Global Testosterone Replacement Therapy Market Size study & Forecast, by Product (Injectables, Topicals, Others) and Regional Analysis, 2022-2029 |
睾酮替代疗法睾酮有多种形式,例如乳液、注射剂、贴片、牙龈/脸颊粘合剂、凝胶或植入物。
老年人口的增加、不健康的生活方式和不断增加的疾病负担预计将增加睾酮缺乏症的患病率,这将在预测期内加速睾酮替代疗法的市场扩张。睾酮缺乏症患病率上升和老年人口增加是预测期内推动市场增长的主要因素。
本调查的目的是定义近年来各个细分市场和国家的市场规模,并在未来几年预测它们的价值。本报告设计内容涵盖调查对象国家产业的定性和定量双方面。
此外也提供市场未来性的成长促进因素和课题等重要方面相关之详细资讯。再加上主要企业的竞争情形和提供产品之详细分析,并涵括利害关係者投资所需的微观市场潜在机会。详细的市场区隔和子区隔如下列。
各产品
注射剂
外用剂
其他
各地区
北美
美国
加拿大
欧洲
英国
德国
法国
西班牙
义大利
其他欧洲
亚太地区
中国
印度
日本
澳洲
韩国
其他亚太地区
南美
巴西
墨西哥
全球其他地区
Global Testosterone Replacement Therapy Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The distribution of testosterone during testosterone replacement treatment may take the form of lotions, injections, patches, gums/buccal adhesives, gels, or implants. A key male hormone called testosterone is in charge of enhancing spermatogenesis, male sexual traits, and reproduction. The prevalence of testosterone insufficiency is anticipated to rise as a result of the growing older population, unhealthy lifestyles, and disease load, which will accelerate the expansion of the market for testosterone replacement therapy over the forecasted period. Major driving factors driving the growth of the market over the forecasted period are growing prevalence of testosterone deficiency and growing number of geriatric populations.
The prevalence of testosterone deficiency in older men over 60 years of age increased by 21.67%, according to a December 2021 article in the Indian Journal of Endocrinology and Metabolism titled "Prevalence of Testosterone Deficiency in Elderly Male and its Association with Frailty and Mobility at a Tertiary Care Centre." Men's androgen levels gradually decline as they age. A need for treatment rather than testosterone is created by such testosterone overproduction, which propels market expansion. In the anticipated timeframe, market share will increase as a result of new product introductions. For instance, the AB generic version of AndroGel 1.62%, Testosterone Gel 1.62% Metered Dose Pump (20.25mg / 1.25g pump actuation), was developed by Xiromed LLC in August 2020. It is an alternate treatment for male diseases linked to persistent low testosterone or testosterone depletion. The negative consequences of testosterone replacement therapy and tight guidelines for product approval, however, will limit market expansion.
The key regions considered for the Global Testosterone Replacement Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America region is estimated to hold dominant position in the worldwide testosterone replacement therapy market over the forecast period, owing to rising number of product launches and approvals connected with androgen replacement therapy by regulatory agencies. For instance, Innovus Pharmaceuticals, Inc., a pharmaceutical firm in commercial development, got approval from Health Canada in February 2019 for its BH Testosterone Booster pills, which are designed to maintain testosterone levels and production in adult males. Additionally, the market for androgen replacement treatment is anticipated to rise significantly in Asia Pacific over the course of the projected period due to an increase in agreements by market participants. For instance, in August 2020, the pharmaceutical technology company Antares Pharma, Inc. and Lunatus Global Medical Supplies ('Lunatus') signed an exclusive distribution agreement for the distribution and marketing of XYOSTED, a testosterone enanthate injection, in Saudi Arabia and the United Arab Emirates (UAE).
Major market players included in this report are:
AbbVie Inc
Endo Pharmaceuticals Inc
Pfizer, Inc
Eli Lilly and Company
Bayer AG
Teva Pharmaceutical Industries Ltd
Ferring Pharmaceuticals
Acerus Pharmaceuticals Corporation
Mylan N.V
Perrigo Company Plc
Recent Developments in the Market:
Global Testosterone Replacement Therapy Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Injectables
Topicals
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable